About BioTransplant
BioTransplant was a Healthcare company based in Boston (United States) founded in 1990. It supplies tested tissues, allografts, and implantable tissue products for medical use. It operates on a B2B model. BioTransplant has raised $9.7 million across 3 funding rounds from investors including Novartis. BioTransplant has completed 1 acquisition, including EligiX. The company is recorded as dissolved. Its focus areas include Medical Devices, Tissue Supply and Implantable Products. Its competitors include GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
BioTransplant, founded in 1990 in Boston, United States, focuses on providing healthcare solutions, developing medical devices, tissue supply, and implantable products. Supplies tested tissues, allografts, and implantable tissue products for medical use. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Boston, United States
- SectorsHealthcare
- Website biotransplant.org
- Social X Facebook
Funding Insights of BioTransplant
BioTransplant has successfully raised a total of $9.7M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $19 million completed in July 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.7M
- Total Rounds 3
- Last Round Post-IPO — $19M
- First Round $2.5M
(Oct 1999)
- Investors Count 1
All 3 funding rounds of BioTransplant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2001 | $19M | Post-IPO | – | – | – |
| Feb 2000 | $9.7M | Private Equity Round | – | – | – |
| Oct 1999 | $2.5M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in BioTransplant
BioTransplant has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Novartis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
R&D focused on manufacturing of drugs for multiple therapeutic areas | 1996 | novartis.com | Basel, Switzerland |
Investor details for BioTransplant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioTransplant
BioTransplant has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EligiX.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Statistical reporting and decision mapping tools | eligix.com | Paris, France | 2016 | Dec 2000 | $55.3M |
Complete acquisition details for BioTransplant
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BioTransplant
4 dated milestones of BioTransplant across 11 years, from founding to its latest funding, stage changes and deals.
- Founded BioTransplant is founded.
- Funding First funding round of $2.5M.
- Acquisition Acquires EligiX.
- Funding Latest funding round, Post-IPO, of $19.0M.
Competitors of BioTransplant
BioTransplant has 8 listed competitors in our database, 6 of them funded. They include GenVault Corporation, iSpecimen, Indivumed, ViaCell and BioStorage Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genvault.com | 2000 | Carlsbad, United States | $47.8M | – | Biosamples are stabilized, transported, stored, and retrieved by GenVault. | |
| ispecimen.com | 2009 | Lexington, United States | $11.86M | 75 | Provider of a biorepository of human clinical specimens | |
| indivumed.com | 2002 | Hamburg, Germany | – | 178 | Biospecimens are collected, preserved, and analyzed for oncology services. | |
| viacellinc.com | 1994 | Cambridge, United States | $63M | – | Provider of services for collecting and preserving umbilical cord blood stem cells | |
| biostorage.com | 2002 | Indianapolis, United States | $8.77M | – | Provides bio repository services | |
| aminochain.io | 2022 | New York, United States | $7.07M | – | A blockchain-based platform for tokenizing and incentivizing stem cell donations | |
| precisionmed.com | 1996 | San Diego, United States | – | – | Human biological materials for research are supplied via a biorepository. | |
| cryoniss.com | 2018 | Macclesfield, United Kingdom | $683,055 | 9 | Provider of biobanking services for life sciences industries |
Detailed competitors of BioTransplant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
10 companies that operate in the same segment as BioTransplant (Medical Equipment & Supplies), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Software and integrated solutions for surgical and radiotherapy applications | 1989 | Munchen, Bayern, Germany | USD 5.38 M | USD 1.18 M | 18 | |
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Collaborative surgical robotic systems are provided for hospital procedures. | 2014 | Cambridge, Cambridgeshire, United Kingdom | USD 1.68 B | USD 48.75 M | 680 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Augmented reality systems for guiding surgical procedures are developed. | 2014 | Yokneam Illit, North District, Israel | USD 142.6 M | – | – | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | – | USD 3.07 B | 10,600 | |
Rapid infusion systems are provided for critically ill patients. | 2012 | Durham, North Carolina, United States | USD 77.98 M | – | – | |
Mobile robots are manufactured for industries including healthcare and agriculture. | 2013 | Odense, Denmark | USD 81.44 M | – | 303 | |
Visualization systems for surgical procedures are developed using machine learning. | 2016 | Seattle, Washington, United States | USD 74.25 M | – | 52 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biotransplant
Complete news archive for BioTransplant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioTransplant
BioTransplant was founded in 1990 and raised its 1st funding round 9 years after it was founded.
BioTransplant is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
BioTransplant is a funded company, having raised a total of $9.7M across 3 funding rounds to date. The company's 1st funding round was a Grant of $2.5M, raised on Oct 1999.
BioTransplant, founded in 1990 in Boston, United States, focuses on providing healthcare solutions, developing medical devices, tissue supply, and implantable products. Supplies tested tissues, allografts, and implantable tissue products for medical use. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
BioTransplant's top competitors include iSpecimen, AminoChain and GenVault Corporation.
BioTransplant has made 1 acquisition, including EligiX.
BioTransplant has 1 investor. Key investors include Novartis.